Aptorum Therapeutics Limited Enters Into Letter of Intent an

Regulatory News:


Aptorum Group Limited , today announced that its wholly owned subsidiary Aptorum Therapeutics Limited has entered into a non-binding Letter of Intent and Term Sheet to merge ... | May 1, 2023

Related Keywords

Boston , Massachusetts , United States , San Diego , California , Singapore , , Singapore Agency For Science , Aptorum Therapeutics Limited , Aptorum Group Or Company , Aptorum Group Form , Paths Innovation , Pathsdx Group , Technology Corporation , Aptorum Group Limited Nasdaq , Dx Program , Daptorum Group , Regulatory News , Group Limited , Euronext Paris , Term Sheet , Paths Innovation Limited , Universal Sequencing Technology Corporation , Innovation Limited , Paths Diagnostics , Sequencing Technology Corporation , Next Generation Sequencing , Aptorum Group Limited , Securities Litigation Reform Act , French Autorit , Des March , Regulations Delegated , Aptorum Group Limited Stock Exchange , News , Information , Press Release , Egulatory , Group , Imited , Oday , Nnounced , Hat , Its , Holly , Wned , Ubsidiary , Aptorum , Herapeutics , Gas , Ntered , Into , Setter , F , Intent , End , Term , Sheet , O , Erge Apm Kyg6096m1226 ,